> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-184/
- Published: 2018-06-17T12:00:00.000Z
- Updated: 2026-09-15T00:13:43.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141710

[**Class 2 for Prostate Tissue Jet System**](https://www.fdaweb.com/class-2-for-prostate-tissue-jet-system/)  
*Federal Register* notice: FDA classifies the fluid jet system for prostate tissue removal into Class 2 (special controls). 06/15/2018

[**Draft Guide on Certain Guidewire Submissions**](https://www.fdaweb.com/draft-guide-on-certain-guidewire-submissions/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Coronary, Peripheral, and Neurovascular Guidewires — Performance Tests and Recommended Labeling.” 06/15/2018

[**Guide on Intravascular Catheters, Wires with Lubricious Coatings**](https://www.fdaweb.com/guide-on-intravascular-catheters-wires-with-lubricious-coatings/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings—Labeling Considerations.” 06/15/2018

[**2 Ferring Menotropins ANDAs Withdrawn**](https://www.fdaweb.com/2-ferring-menotropins-andas-withdrawn/)  
*Federal Register* notice: FDA withdraws approval of two Ferring Pharmaceuticals ANDAs because the company notified the agency that they were no longer marketed. 06/15/2018

[**Brain Trauma Assessment Tests are Class 2** ](https://www.fdaweb.com/brain-trauma-assessment-tests-are-class-2/)*Federal Register* notice: FDA classifies brain trauma assessment tests into Class 2 (special controls). 06/14/2018

[**Endoscopic Cutting Systems Placed in Class 2**](https://www.fdaweb.com/endoscopic-cutting-systems-placed-in-class-2/)  
*Federal Register* notice: FDA classifies the endoscopic electrosurgical clip cutting system into Class 2 (special controls). 06/14/2018

[**Draft Guide on Patient-Focused Drug Development**](https://www.fdaweb.com/draft-guide-on-patient-focused-drug-development/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Patient-Focused Drug Development: Collecting Comprehensive and Representative Input.” 06/14/2018

[**Draft Guide on Humanitarian Device Exemption Program**](https://www.fdaweb.com/draft-guide-on-humanitarian-device-exemption-program-2/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Humanitarian Device Exemption (HDE) Program.” 06/14/2018